APO Research
Talk to an analyst

APO RESEARCH · REPORT

Post herpetic Neuralgia Treatment

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

Selected research

Industry Growth & Trends

Global Post herpetic Neuralgia Treatment Industry Growth and Trends Forecast to 2032

21 December 202586 pages

Choose your research edition.

Industry ResearchPost herpetic Neuralgia Treatment Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Post herpetic Neuralgia Treatment Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Post herpetic Neuralgia Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Post herpetic Neuralgia Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Post herpetic Neuralgia Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for post herpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.

According to APO Research, the global Post herpetic Neuralgia Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Post herpetic Neuralgia Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Post herpetic Neuralgia Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Post herpetic Neuralgia Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Post herpetic Neuralgia Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Post herpetic Neuralgia Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Post herpetic Neuralgia Treatment Market by Company

Pfizer

Arbor Pharma

Assertio Therapeutics

Endo Pharma

Teikoku Pharma

Teva

Mylan

Hengrui Medicine

Post herpetic Neuralgia Treatment Segment by Type

Anticonvulsants

Skin Patch

Other

Post herpetic Neuralgia Treatment Segment by Distribution Channel

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Post herpetic Neuralgia Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Post herpetic Neuralgia Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Post herpetic Neuralgia Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Post herpetic Neuralgia Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Post herpetic Neuralgia Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Post herpetic Neuralgia Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Post herpetic Neuralgia Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Post herpetic Neuralgia Treatment Market Share by Region (2021-2026) Table 4. Global Post herpetic Neuralgia Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Post herpetic Neuralgia Treatment Market Share by Region (2027-2032) Table 6. Global Post herpetic Neuralgia Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Post herpetic Neuralgia Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2026) Table 9. Global Post herpetic Neuralgia Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Post herpetic Neuralgia Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel (2021-2026) & (US$ Million) Table 23. Global Post herpetic Neuralgia Treatment Market Size Share by Distribution Channel (2021-2026) Table 24. Global Post herpetic Neuralgia Treatment Market Size Forecasted by Distribution Channel (2027-2032) & (US$ Million) Table 25. Global Post herpetic Neuralgia Treatment Market Size Share Forecasted by Distribution Channel (2027-2032) Table 26. North America Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 27. North America Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 28. Europe Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 29. Europe Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 30. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 31. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 32. Latin America Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 33. Latin America Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 34. Middle East and Africa Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026) & (US$ Million) Table 35. Middle East and Africa Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2027-2032) & (US$ Million) Table 36. Post herpetic Neuralgia Treatment Industry Trends Table 37. Post herpetic Neuralgia Treatment Industry Drivers Table 38. Post herpetic Neuralgia Treatment Industry Opportunities and Challenges Table 39. Post herpetic Neuralgia Treatment Industry Restraints Table 40. Global Post herpetic Neuralgia Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Post herpetic Neuralgia Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Post herpetic Neuralgia Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Post herpetic Neuralgia Treatment Key Company Headquarters & Area Served Table 44. Global Post herpetic Neuralgia Treatment Company, Product Type & Application Table 45. Global Post herpetic Neuralgia Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Post herpetic Neuralgia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Pfizer Post herpetic Neuralgia Treatment Product Portfolio Table 52. Pfizer Recent Development Table 53. Arbor Pharma Company Information Table 54. Arbor Pharma Business Overview Table 55. Arbor Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 57. Arbor Pharma Recent Development Table 58. Assertio Therapeutics Company Information Table 59. Assertio Therapeutics Business Overview Table 60. Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio Table 62. Assertio Therapeutics Recent Development Table 63. Endo Pharma Company Information Table 64. Endo Pharma Business Overview Table 65. Endo Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 67. Endo Pharma Recent Development Table 68. Teikoku Pharma Company Information Table 69. Teikoku Pharma Business Overview Table 70. Teikoku Pharma Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio Table 72. Teikoku Pharma Recent Development Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Teva Post herpetic Neuralgia Treatment Product Portfolio Table 77. Teva Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Mylan Post herpetic Neuralgia Treatment Product Portfolio Table 82. Mylan Recent Development Table 83. Hengrui Medicine Company Information Table 84. Hengrui Medicine Business Overview Table 85. Hengrui Medicine Post herpetic Neuralgia Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio Table 87. Hengrui Medicine Recent Development Table 88. North America Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Post herpetic Neuralgia Treatment Market Share by Country (2021-2026) Table 91. North America Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Post herpetic Neuralgia Treatment Market Share Forecast by Country (2027-2032) Table 93. Europe Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe Post herpetic Neuralgia Treatment Market Share by Country (2021-2026) Table 96. Europe Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe Post herpetic Neuralgia Treatment Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Country (2021-2026) Table 101. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific Post herpetic Neuralgia Treatment Market Share Forecast by Country (2027-2032) Table 103. Latin America Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America Post herpetic Neuralgia Treatment Market Share by Country (2021-2026) Table 106. Latin America Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America Post herpetic Neuralgia Treatment Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2021-2026) Table 111. Middle East & Africa Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa Post herpetic Neuralgia Treatment Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Post herpetic Neuralgia Treatment Product Image Figure 3. Global Post herpetic Neuralgia Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Post herpetic Neuralgia Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Post herpetic Neuralgia Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Post herpetic Neuralgia Treatment Market Share by Region (2021-2032) Figure 7. North America Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Anticonvulsants Image Figure 13. Global Anticonvulsants Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Skin Patch Image Figure 15. Global Skin Patch Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Post herpetic Neuralgia Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Post herpetic Neuralgia Treatment Market Share by Type 2025 VS 2032 Figure 20. North America Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2032) Figure 21. Europe Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2032) Figure 23. Latin America Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Post herpetic Neuralgia Treatment Market Size Share by Type (2021-2032) Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Retail Pharmacies Image Figure 30. Global Retail Pharmacies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Post herpetic Neuralgia Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Post herpetic Neuralgia Treatment Market Share by Application 2025 VS 2032 Figure 33. North America Post herpetic Neuralgia Treatment Market Size Share by Application (2021-2032) Figure 34. Europe Post herpetic Neuralgia Treatment Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Post herpetic Neuralgia Treatment Market Size Share by Application (2021-2032) Figure 36. Latin America Post herpetic Neuralgia Treatment Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Post herpetic Neuralgia Treatment Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Post herpetic Neuralgia Treatment Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Post herpetic Neuralgia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Post herpetic Neuralgia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 43. Europe Post herpetic Neuralgia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Post herpetic Neuralgia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 46. Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 49. Latin America Post herpetic Neuralgia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Post herpetic Neuralgia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 52. Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Post herpetic Neuralgia Treatment Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Anticonvulsants
  • Skin Patch
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Pfizer
  • Arbor Pharma
  • Assertio Therapeutics
  • Endo Pharma
  • Teikoku Pharma
  • Teva
  • Mylan
  • Hengrui Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Post herpetic Neuralgia Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Post herpetic Neuralgia Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Post herpetic Neuralgia Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Post herpetic Neuralgia Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Post herpetic Neuralgia Treatment Market Size (2021-2032)
  8. 1.5.1 North America Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Post herpetic Neuralgia Treatment Market Size Growth Rate (2021-2032)
2 Post herpetic Neuralgia Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Anticonvulsants
  3. 2.1.2 Skin Patch
  4. 2.1.3 Other
  5. 2.2 Global Post herpetic Neuralgia Treatment Market Size by Type
  6. 2.2.1 Global Post herpetic Neuralgia Treatment Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Post herpetic Neuralgia Treatment Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Post herpetic Neuralgia Treatment Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Post herpetic Neuralgia Treatment Market Size by Regions
  10. 2.3.1 North America Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Post herpetic Neuralgia Treatment Market Size Breakdown by Type (2021-2026)
3 Post herpetic Neuralgia Treatment Market by Distribution Channel
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacies
  3. 3.1.2 Online Pharmacies
  4. 3.1.3 Retail Pharmacies
  5. 3.2 Global Post herpetic Neuralgia Treatment Market Size by Distribution Channel
  6. 3.2.1 Global Post herpetic Neuralgia Treatment Market Size Overview by Distribution Channel (2021-2032)
  7. 3.2.2 Global Post herpetic Neuralgia Treatment Historic Market Size Review by Distribution Channel (2021-2026)
  8. 3.2.3 Global Post herpetic Neuralgia Treatment Market Size Forecasted by Distribution Channel (2027-2032)
  9. 3.3 Global Post herpetic Neuralgia Treatment Market Size by Regions
  10. 3.3.1 North America Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026)
  11. 3.3.2 Europe Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026)
  12. 3.3.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026)
  13. 3.3.4 South America Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026)
  14. 3.3.5 Middle East and Africa Post herpetic Neuralgia Treatment Market Size Breakdown by Distribution Channel (2021-2026)
4 Global Market Dynamics
  1. 4.1 Post herpetic Neuralgia Treatment Industry Trends
  2. 4.2 Post herpetic Neuralgia Treatment Industry Drivers
  3. 4.3 Post herpetic Neuralgia Treatment Industry Opportunities and Challenges
  4. 4.4 Post herpetic Neuralgia Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Post herpetic Neuralgia Treatment Revenue (2021-2026)
  2. 5.2 Global Post herpetic Neuralgia Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Post herpetic Neuralgia Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Post herpetic Neuralgia Treatment Company, Product Type & Application
  5. 5.5 Global Post herpetic Neuralgia Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Post herpetic Neuralgia Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Post herpetic Neuralgia Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Post herpetic Neuralgia Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Post herpetic Neuralgia Treatment Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Arbor Pharma
  8. 6.2.1 Arbor Pharma Company Information
  9. 6.2.2 Arbor Pharma Business Overview
  10. 6.2.3 Arbor Pharma Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Arbor Pharma Post herpetic Neuralgia Treatment Product Portfolio
  12. 6.2.5 Arbor Pharma Recent Developments
  13. 6.3 Assertio Therapeutics
  14. 6.3.1 Assertio Therapeutics Company Information
  15. 6.3.2 Assertio Therapeutics Business Overview
  16. 6.3.3 Assertio Therapeutics Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Assertio Therapeutics Post herpetic Neuralgia Treatment Product Portfolio
  18. 6.3.5 Assertio Therapeutics Recent Developments
  19. 6.4 Endo Pharma
  20. 6.4.1 Endo Pharma Company Information
  21. 6.4.2 Endo Pharma Business Overview
  22. 6.4.3 Endo Pharma Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Endo Pharma Post herpetic Neuralgia Treatment Product Portfolio
  24. 6.4.5 Endo Pharma Recent Developments
  25. 6.5 Teikoku Pharma
  26. 6.5.1 Teikoku Pharma Company Information
  27. 6.5.2 Teikoku Pharma Business Overview
  28. 6.5.3 Teikoku Pharma Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Teikoku Pharma Post herpetic Neuralgia Treatment Product Portfolio
  30. 6.5.5 Teikoku Pharma Recent Developments
  31. 6.6 Teva
  32. 6.6.1 Teva Company Information
  33. 6.6.2 Teva Business Overview
  34. 6.6.3 Teva Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Teva Post herpetic Neuralgia Treatment Product Portfolio
  36. 6.6.5 Teva Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Post herpetic Neuralgia Treatment Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Hengrui Medicine
  44. 6.8.1 Hengrui Medicine Company Information
  45. 6.8.2 Hengrui Medicine Business Overview
  46. 6.8.3 Hengrui Medicine Post herpetic Neuralgia Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Hengrui Medicine Post herpetic Neuralgia Treatment Product Portfolio
  48. 6.8.5 Hengrui Medicine Recent Developments
7 North America
  1. 7.1 North America Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Post herpetic Neuralgia Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Post herpetic Neuralgia Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Post herpetic Neuralgia Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst